Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The major compound in orange essential oil (OEO) is limonene, which has in vitro anthelmintic properties; however, a safe in vivo dose has not been defined for animals. Therefore, a pilot study was conducted to evaluate the effect of an OEO formulation for the control of gastrointestinal nematodes in sheep and to investigate adverse reactions in lambs after OEO administration. A total of 17 lambs received an oral OEO formulation at a concentration of 600 mg/mL, in doses of 200, 300, and 600 mg/kg. The most common clinical signs observed were head shaking (88.8%), backward head movement (51.1%), and ataxia (74.4%). Lambs treated with 600 mg/kg of OEO showed more severe combined clinical signs and longer duration of symptoms, presenting adverse reactions for up to 2 h after OEO administration. Testing of different doses and formulations with slower release of the active ingredient is recommended to minimize or eliminate these effects.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vprsr.2021.100593 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!